ADHD Medication May Boost Kids' Arrhythmia RiskADHD Medication May Boost Kids' Arrhythmia Risk
Children and young people prescribed methylphenidate, commonly used in ADHD, have an increased risk for arrhythmia in the weeks after initiation of treatment. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - June 7, 2016 Category: Psychiatry Tags: Psychiatry News Source Type: news
ADHD Meds May Pose Heart Risks for Some Kids
Study found slightly higher chance of irregular heartbeat shortly after starting methylphenidate (Source: WebMD Health)
Source: WebMD Health - June 1, 2016 Category: Consumer Health News Source Type: news
ADHD Meds May Pose Heart Risks for Some Kids
Study found slightly higher chance of irregular heartbeat shortly after starting methylphenidate
Source: HealthDay
Related MedlinePlus Pages: Attention Deficit Hyperactivity Disorder, Medicines and Children (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 1, 2016 Category: Consumer Health News Source Type: news
ADHD drugs 'linked to risk of heart rhythm problems'
Use of methylphenidate in children and young people with attention deficit hyperactivity disorder is linked to an increased risk of arrhythmia shortly after the start of treatment, warn researchers. (Source: Nursing Times)
Source: Nursing Times - June 1, 2016 Category: Nursing Source Type: news
Methylphenidate tied to greater risk of arrhythmia in children, adolescents
Children and adolescents with attention-deficit/hyperactivity disorder who are prescribed methylphenidate to manage their conditions stand at a higher risk for arrhythmia and other, more serious,... (Source: Pediatric News)
Source: Pediatric News - May 31, 2016 Category: Journals (General) Source Type: news
Methylphenidate tied to greater risk of arrhythmia in children, adolescents
Children and adolescents with attention-deficit/hyperactivity disorder who are prescribed methylphenidate to manage their conditions stand at a higher risk for arrhythmia and other, more serious,... (Source: Family Practice News)
Source: Family Practice News - May 31, 2016 Category: Primary Care Source Type: news
Methylphenidate Tied to Increased Arrhythmia Risk in Kids with ADHD (FREE)
By Kelly Young
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Use of methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is associated with increased risk for arrhythmia — and potentially elevated risk for myocardial infarction — according to a self-controlled case series study in The BMJ. Using a South Korean … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 31, 2016 Category: Primary Care Source Type: news
Quillivant XR (Methylphenidate Hydrochloride Extended Release Oral Suspension, CII ) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 25, 2016 Category: Drugs & Pharmacology Source Type: news
Quantifying the benefits and risks of psychostimulant medication for ADHD
Establishing the benefits and possible risks of psychostimulant medication as a treatment for childhood Attention Deficit Hyperactivity Disorder (ADHD) is vital, says Philip Shaw, M.D., Ph.D., a researcher with NHGRI's Social and Behavioral Research Branch. His review of a recent meta-analysis on the use of the psychostimulant methylphenidate for ADHD appeared in the Journal of the American Medical Association (JAMA) and is the subject of a (Source: NHGRI Homepage Highlights)
Source: NHGRI Homepage Highlights - May 9, 2016 Category: Genetics & Stem Cells Source Type: news
Could ADHD Drugs Lower Kids' Bone Density?
FRIDAY, April 1, 2016 -- Commonly prescribed drugs to treat attention-deficit hyperactivity disorder (ADHD) may affect bone density, a new study says.
Researchers found that young people who take stimulants such as methylphenidate (Ritalin,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 1, 2016 Category: Journals (General) Source Type: news
Keith Conners, Father of ADHD, Regrets Its Current Misuse
Keith Conners can rightly be called the "Father of ADHD". He was there at the birth of the disorder and probably knows more about it than anyone else on the planet. Fifty years ago, well before there was an ADHD diagnosis, Dr Conners analyzed the data on the very first randomized trial of dextro-amphetamine (Dexedrine)- studying its efficacy in kids with severe restlessness and impulsivity. Soon after, he conducted the first trial of the then new drug, methylphenidate (Ritalin). Dr Conners developed the standard rating scales used for assessing children in research and clinical practice and for measuring the impact of tre...
Source: Science - The Huffington Post - March 28, 2016 Category: Science Source Type: news
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of harmful effects in non-randomised studies
The objectives are as follows:
To assess the harmful effects of methylphenidate treatment for children and adolescents with attention deficit hyperactivity disorder (ADHD) in non-randomised studies. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 17, 2016 Category: Consumer Health News Source Type: news
ADHD medication for kids: Is it safe? Does it help?
This study doesn’t answer the question of whether there are too many children on medication. Interestingly (and often surprisingly, for many people), other studies have shown that at least one-third and up to one-half of children with significant developmental and psychological problems go untreated. That’s a lot of kids who need help, either through some sort of therapy, educational support, or (for some) medication. This study also only addresses one medication, although it is the one that is most popularly prescribed.
Deciding what treatment option to use when you have a child with ADHD isn’t easy. Medication isnâ...
Source: New Harvard Health Information - March 4, 2016 Category: Consumer Health News Authors: Ellen Braaten, Ph.D. Tags: Behavioral Health Brain and cognitive health Children's Health Drugs and Supplements Parenting ADHD ADHD medications Source Type: news
Methylphenidate Hydrochloride ER Capsules/Tablets (Updated - Resolved)
Updated Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 24, 2016 Category: Drugs & Pharmacology Source Type: news
Seven fatalities associated with ethylphenidate - Maskell PD, Smith PR, Cole R, Hikin L, Morley SR.
Ethylphenidate is a stimulant novel psychoactive substance that is an analogue of the prescription drug methylphenidate (Ritalin(®)). Methylphenidate is used commonly for the treatment of attention deficit hyperactivity disorder. Due to its stimulant effe... (Source: SafetyLit)
Source: SafetyLit - February 19, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
